 Self-report questionnaires and hbA1c capillary blood collection kits will be administered at baseline prior to the intervention, six-months and twelve-months. Differences between baseline and followup scores will be used to determine if participants have benefited from the intervention, using intent-to-treat methodology. Subgroups and delivery method small-group or on-line will be compared using repeated measures and analyses of covariance. 